Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinoma. [electronic resource]
Producer: 20130117Description: 6-13 p. digitalISSN:- 1423-0232
- Aged
- Aged, 80 and over
- Benzenesulfonates -- therapeutic use
- Carcinoma, Hepatocellular -- complications
- Diarrhea -- chemically induced
- Female
- Follow-Up Studies
- Humans
- Liver Cirrhosis -- complications
- Liver Neoplasms -- complications
- Male
- Middle Aged
- Nausea -- chemically induced
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Prospective Studies
- Pyridines -- therapeutic use
- Skin Diseases -- chemically induced
- Sorafenib
- Survival Rate
- Treatment Outcome
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.